Profile data is unavailable for this security.
About the company
Vaidya Sane Ayurved Laboratories Limited is an India-based company, which is engaged in research and development in ayurvedic medicines and the sale of ayurvedic medicines and products through its various franchises and own clinics. The Company is involved in providing ayurved medical professional services across its various clinics, including panchkarma and other ayurvedic treatments through the running of ayurvedic hospitals. It uses diagnostics, diet, physiotherapy and ayurveda to provide heart disease, diabetes, hypertension and obesity reversal treatments to its patients. The Company operates approximately 337 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, Haryana, Punjab, Himachal Pradesh, Uttarakhand, West Bengal, Jammu, Kerala, Orissa and Chhattisgarh. It owns about 55 clinics, 59 are OPD's and Mini Clinic and 223 are franchise clinics. The Company operates two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur.
- Revenue in INR (TTM)1.05bn
- Net income in INR36.30m
- Incorporated1999
- Employees632.00
- LocationVaidya Sane Ayurved Laboratories LtdShukrawar PethFl. 5, 1047, Shriram BhawanTHANE 400604IndiaIND
- Websitehttps://madhavbaug.org/clinic-hospital-locator/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Krebs Biochemicals And Industries Ltd | 499.09m | -208.21m | 1.47bn | 210.00 | -- | -- | -- | 2.95 | -9.50 | -9.50 | 22.86 | -- | -- | -- | -- | 2,376,624.00 | -- | -18.88 | -- | -29.04 | 86.28 | 11.95 | -41.72 | -59.37 | -- | -3.78 | -- | -- | -12.68 | 9.07 | 44.55 | -- | 28.63 | -- |
| Mangalam Drugs and Organics Ltd | 3.57bn | -169.87m | 1.60bn | 523.00 | -- | -- | -- | 0.4486 | -10.74 | -10.74 | 225.21 | -- | -- | -- | -- | 6,834,930.00 | -- | 3.70 | -- | 6.50 | 26.38 | 29.07 | -4.75 | 2.87 | -- | -0.5682 | -- | -- | -17.47 | 5.91 | -93.54 | -42.32 | 11.78 | -- |
| Bal Pharma Ltd | 3.27bn | 35.19m | 1.62bn | -- | 47.28 | -- | 11.99 | 0.496 | 2.17 | 2.17 | 209.85 | -- | -- | -- | -- | -- | -- | 0.1785 | -- | 0.4782 | 44.02 | 43.81 | 1.08 | 0.1865 | -- | 1.34 | -- | 132.38 | 8.18 | 7.54 | -54.17 | -1.56 | 31.09 | 0.00 |
| Vaishali Pharma Ltd | 801.21m | 58.38m | 1.76bn | -- | 30.71 | -- | 27.75 | 2.20 | 5.15 | 5.15 | 68.64 | -- | -- | -- | -- | -- | -- | 3.32 | -- | 8.64 | 17.72 | 15.06 | 7.29 | 3.71 | -- | 4.37 | -- | -- | -8.12 | 0.5072 | 64.12 | 52.62 | -4.18 | -- |
| Alpa Laboratories Limited | 1.15bn | 178.77m | 1.89bn | 318.00 | 10.52 | -- | 9.52 | 1.64 | 8.54 | 8.54 | 54.78 | -- | -- | -- | -- | 3,610,371.00 | -- | 5.39 | -- | 6.71 | 35.30 | 33.85 | 15.57 | 7.88 | -- | 109.23 | -- | -- | -17.20 | 8.14 | -10.71 | 34.99 | -10.58 | -- |
| Vaidya Sane Ayurved Laboratories Ltd | 1.05bn | 36.30m | 1.94bn | 632.00 | 53.40 | 3.54 | 29.13 | 1.86 | 3.46 | 3.46 | 99.55 | 52.12 | 1.74 | 11.90 | 20.17 | 1,654,093.00 | 6.04 | -- | 7.39 | -- | 71.79 | -- | 3.47 | -- | 2.57 | 16.25 | 0.0683 | -- | 32.55 | -- | 49.62 | -- | -- | -- |
| SMS Lifesciences India Ltd | 2.96bn | 49.05m | 2.00bn | 567.00 | 40.76 | -- | 12.46 | 0.6759 | 16.23 | 16.23 | 978.01 | -- | -- | -- | -- | 5,218,087.00 | -- | 5.33 | -- | 8.84 | 29.00 | 26.60 | 0.6645 | 4.99 | -- | 0.8533 | -- | 2.32 | -9.77 | 7.73 | -54.65 | 12.01 | 69.24 | -- |
| Bafna Pharmaceuticals Ltd | 1.53bn | 112.65m | 2.36bn | 588.00 | 20.20 | -- | 14.27 | 1.54 | 4.93 | 4.93 | 65.88 | -- | -- | -- | -- | 2,607,335.00 | -- | 0.228 | -- | 0.3636 | 30.53 | 34.36 | 7.35 | 0.3193 | -- | 4.72 | -- | -- | 35.60 | 19.60 | 117.36 | -- | 130.43 | -- |
| Brooks Laboratories Ltd | 744.61m | -142.85m | 2.37bn | 296.00 | -- | -- | -- | 3.19 | -5.65 | -5.65 | 29.38 | -- | -- | -- | -- | 2,515,585.00 | -- | -12.10 | -- | -19.53 | 30.02 | 26.63 | -19.18 | -28.01 | -- | 0.0672 | -- | -- | -30.69 | 2.12 | -85.13 | -- | -39.43 | -- |
